Skip to main content
. 2019 May 21;25(19):2354–2364. doi: 10.3748/wjg.v25.i19.2354

Figure 2.

Figure 2

Level of faecal calprotectin at baseline and after 12 wk of anti-tumor necrosis factor therapy in patients with Crohn’s disease achieving steroids-free remission (Crohn’s disease activity index < 150 and C-reactive protein < 2.9 mg/L and faecal calprotectin < 250 µg/g with no therapeutic intensification and no surgery) or not at week 52. CFREM: Corticosteroids-free remission.